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Abstract
Background: Indian Asians are at increased risk of cardiovascular death which does not appear to be explained by
conventional risk factors. As microvascular disease is also more prevalent in Indian Asians, and as it is thought to
play a role in the development of macrovascular disease, we decided to determine whether impaired
microcirculation could contribute to this increased cardiovascular risk in Indian Asians.
Methods: Forearm skin laser Doppler fluximetry in response to heating and ischaemia was assessed in 83
Europeans (41 with angiographically confirmed atherosclerotic coronary artery disease (CAD) and 42 from the
general population) and 84 Indian Asians (41 with CAD). Explanations for differences in microvascular function
were sought using multivariate analysis including conventional cardiovascular risk factors.
Results: Compared to ethnically matched control populations both Europeans and Indian Asians with CAD had
poorer microvascular responses to heating than those without (117(95% CI 105-131) vs. 142(130-162) arbitrary units,
(au) for Europeans and 111(101-122) vs. 141(131-153)au for Indian Asians) and to ischaemia (44(38-50) vs. 57(49-67)
au & 39(34-45) vs. 49(43-56)au respectively). These differences were not accounted for by conventional
cardiovascular risk factors. There was no ethnic difference in the attenuation of microvascular function associated
with CAD.
Conclusion: Patients of European and Indian Asian descent with symptomatic CAD have poorer microvascular
maximal tissue perfusion and reactive hyperaemia in the skin compared to ethnically matched asymptomatic
control populations. Despite the increased cardiovascular risk in Indian Asians, the attenuation of microvascular
function associated with CAD was equivalent in the ethic groups. This suggests that in Indian Asians
microcirculation does not explain the increased susceptibility to CAD.
Background
People of Indian Asian descent are at increased risk of
cardiovascular disease[1,2]. This is only partly explained
by the increased prevalence and susceptibility to insulin
resistance and associated central obesity, hyperglycaemia
and dyslipidaemia[3]. These risk factors are also predic-
tors of microvascular dysfunction[4], which may account
for the increased incidence of microvascular target
organ damage reported in people of South Asian decent
including microalbuminuria [5,6], diabetic retinopathy
[7] and nephropathy [8].
Although an ethnic difference in brachial artery
endothelial function has previously been reported[9],
comparisons of microvascular function (< 80 μm in dia-
meter) have not been explored. We cannot assume that
abnormalities observed in the large vessels reflect those
in the microcirculation, given the differences in struc-
ture, function and regulation of these vessels. Skin ves-
sels are an easily accessible location to explore the
microvasculature. They can be investigated non-inva-
sively in large patient cohorts and mirror disturbances
in other vascular beds. These measures have previously
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and left ventricular hypertrophy[11]. Disturbances in
skin microcirculatory reactive hyperaemia correlate posi-
tively with Framingham risk scores[12] in otherwise
healthy volunteers.
We hypothesised that people with proven coronary
artery disease would have attenuated microvascular
function compared to those without and that Indian
Asians would have poorer microvascular responses than
Europeans for any given degree of coronary artery
disease.
Methods
Recruitment details have been published elsewhere[13].
In brief, the study population was recruited from two
sources: the first consisted of consecutively recruited
men with established clinical coronary artery disease,
referred to cardiology clinics at St Mary’s Hospital and
Ealing Hospital in London, UK, with a minimum 50%
stenosis in at least one coronary artery and evidence of
atherosclerosis elsewhere in the coronary arteries con-
firmed angiographically (CAD +ve). A control popula-
tion of men with no known coronary artery disease,
matched to CAD+ve volunteers by ethnic group and 5
year age band, were drawn from a family practice regis-
ter in North-West London that used both of the hospi-
tals as secondary referral centres (CAD -ve). More than
97% of individuals are registered on such practice regis-
ters[14]. Maintenance of registers of patients with cor-
onary artery disease is an incentivised requirement
under the family practitioner contract, therefore those
with symptomatic atherosclerotic disease can accurately
be excluded. This was further cross-checked prior to
enrolment, by a review of patient history and medication
list to ensure no subjects with known coronary artery
disease were included due to any lag between diagnosis
and updating the primary care register.
St Mary’s Hospital local research ethics committee
approved the study and all participants gave written
informed consent.
Study investigations
All participants were invited to attend St Mary’sH o s p i -
tal for investigation. Baseline demographic, medical his-
tory and lifestyle data were collected. Measures of
height, weight and central obesity were performed
according to a standard protocol[3]. A resting electro-
cardiogram (ECG) was performed and sitting brachial
systolic (SBP) and diastolic (DBP) blood pressures and
heart rate were measured as the average of three read-
ings using a validated automatic device (Omron 705CP,
Omron Healthcare Europe B.V., Hoofddorp, the Nether-
lands). Fasting bloods were taken and analysed by the
on-site laboratory, which is a member of the appropriate
U.K. National Quality Assessment Scheme. Glucose and
lipid levels were determined using the AU600 Olympus
Diagnostic analyser (Olympus Diagnostic Systems, East-
leigh, UK) and insulin was determined by Abbott
Axsym immunometric assay (Abbott Laboratories,
Abbott Park, Illinois, USA). CRP was measured with a
highly sensitive sandwich enzyme immunoassay, using
rabbit anti-human CRP immunoglobulin as a catching
and detecting antibody (Dako, Copenhagen, Denmark)
Microvascular assessment
As the skin is a thermoregulatory organ, resting mea-
surements exhibit a high degree of within-person varia-
bility and dynamic responses to stimuli are preferred.
We measured, using established protocols[15], responses
to heating and to ischaemia in arbitrary units (au) with
laser Doppler fluximetry (DRT4, Moor Instruments,
Axminster, UK) in an air conditioned room with the
temperature fixed at 22°C.
Response to heating (maximum hyperaemia)
Ab r a s s0 . 7c m
2 area heated disc was fixed on a flat
region, not overlying any large vessels, on the left fore-
arm. This was maintained at 42°C for 30 minutes. The
maximum hyperaemic response was assessed by measur-
ing skin vessel flux (perfusion) at eight equidistant
points in the disk area and averaged. The intra-subject,
intra-observer variability over a period of 3 months or
less is 8.2 ± 2.0% within this study. This was measured
in 12 individuals, three of whom had diabetes. The
variability within a single subject over a 10-year period
is 10%.
Response to ischaemia (reactive hyperaemia)
A sphygmomanometer cuff was inflated to 30 mmHg
above systolic blood pressure for three minutes. During
occlusion, the flux generated by Brownian motion of the
interstitial fluid and intracellular fluid at the heated site
was recorded (biological zero). At three minutes the
occlusion was released prompting a reactive increase in
flow. In an unheated area of skin the peak value of this
flow was recorded. The intra-subject reproducibility of
the peak response is 16.2 ± 2.8% studied in 22 indivi-
duals (10 with confirmed atherosclerotic disease) on 2
occasions.
Statistical analysis
Analyses were performed using STATA version 8
(Macintosh Version; Statacorp LP, USA). All normal
data are presented as mean ± SD. Skewed data were log
transformed and are presented as geometric means (95%
confidence interval). Biological zero was subtracted from
maximum hyperaemic response and reactive hyperaemia
in keeping with common practice [16-18]. Statistical sig-
nificance for categorical variables was calculated using
the chi-squared test and ANOVA for continuous vari-
ables. In exploring independent determinants of micro-
vascular responses, a measure of each conventional risk
factor (blood pressure, lipid profile, obesity and insulin
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2)
was included in a multivariate model. Significance of
contribution to this model was tested by the likelihood
ratio statistic (LRS). A result was deemed significant if p
< 0.05. In keeping with the recommendations of Cup-
ples[19] and Rothman[20] the measured significance of
the variables of interest is reported without adjustment
for multiple testing.
Results
Clinical characteristics
Patients of Indian Asian descent were younger than
their European counterparts (Table 1), however had the
same duration of diagnosed cardiovascular disease(from
time of initial presentation to cardiologist), implying a
younger age at onset of symptoms. In both CAD +ve
and CAD -ve populations, Indian Asians had lower
weight (p < 0.0001) and systolic (p = 0.005), but not
diastolic, blood pressure than their European compara-
tors. The CAD +ve volunteers had higher insulin and
HbA1c than the CAD -ve population, and Indian Asians
had higher HbA1c than Europeans whether recruited
from cardiology services or the general practice register.
There was no ethnic difference in use of statin or anti-
hypertensive/anti-anginal therapy.
Those with clinically apparent coronary artery disease
(CAD +ve) had lower maximum microvascular hyperae-
mia and reactive hyperaemia compared to the CAD -ve
comparators in each ethnic group. There was a trend (p
= 0.06) towards lower reactive hyperaemia in Indian
Asians compared to Europeans. Otherwise there were
no ethnic differences in microvascular function in either
maximum hyperaemia or reactive hyperaemia.
In keeping with previous work using this technique
[10,21], there was a negative association between maxi-
mum hyperaemia and HbA1c and insulin, such that
Table 1 Baseline characteristics (mean ± SD except skewed data where geometric mean (95%CI) shown) stratified by
enrollment group and ethnicity
No known CAD Established CAD P by
Variable Europeans Indian Asians Europeans Indian Asians Ethnicity CAD group
N 4 14 34 24 1
Age (years) 61 ± 7 58 ± 9 67 ± 9 61 ± 8 0.0001 0.0004
Time since diagnosis (days) 65 ± 7 72 ± 9 0.08
systolic BP (mmHg) 143 ± 21 135 ± 16 144 ± 19 133 ± 15 0.005 0.8
diastolic BP (mmHg) 85 ± 10 84 ± 9 81 ± 8 79 ± 77 0.2 0.003
Heart Rate (bpm) 63 ± 11 65 ± 11 61 ± 9 65 ± 11 0.1 0.5
Weight (kg) 84 ± 15 72 ± 13 86 ± 12 77 ± 10 < 0.0001 0.08
BMI (kg/m
2) 28 ± 4 26 ± 4 28 ± 4 27 ± 3 0.0009 0.2
Waist circumference (cm) 100 ± 12 94 ± 10 103 ± 8 100 ± 9 0.004 0.005
Waist:hip ratio 0.99 ± 0.06 0.99 ± 0.10 0.98 ± 0.08 1.01 ± 0.05 0.3 0.8
Fasting insulin* (iu/dl) 41(33-50) 47(39-58) 54(45-64) 66(54-79) 0.06 0.002
Fasting glucose (mmol/l)* 5.5(5.2 - 5.8) 5.6(5.3-6.0) 5.9(5.5-6.3) 6.2(5.6-6.8) 0.3 0.03
HbA1c (%)* 5.7(5.5-5.9) 6.2(6.0-6.4) 5.9(5.7-6.2) 6.7(6.3-7.1) < 0.0001 0.006
eGFR (MDRD equation) 73 ± 14 78 ± 12 64 ± 13 68 ± 16 0.1 0.0004
C-Reactive protein(mg/l)* 1.7(1.1-2.7) 1.6(1.1-2.3) 2.3(1.6-3.2) 1.3(1.0-1.8) 0.1 0.7
Total cholesterol (mmol/l) 4.7 ± 1.0 4.8 ± 0.8 4.1 ± 0.9 4.1 ± 1.0 0.99 < 0.0001
HDL cholesterol (mmol/l) 1.17(1.08-1.26) 1.19(1.10-1.28) 1.14(1.06-1.23) 1.04(0.96-1.12) 0.3 0.04
Cholesterol:HDL ratio* 4.0(3.6-4.3) 4.0(3.7-4.2) 3.5(3.3-3.8) 3.8(3.5-4.2) 0.4 0.06
LDL cholesterol (mmol/l)* 2.8(2.5-3.2) 2.8(2.6-3.0) 2.1(1.9-2.4) 2.1(1.9-2.3) 0.9 < 0.0001
Triglycerides (mmol/l)* 1.2(1.1-1.4) 1.2(1.1-1.4) 1.3(1.1-1.5) 1.4(1.2-1.7) 0.4 0.1
Statin therapy n (%) 12(29) 9(21) 36(86) 33(81) 0.3 < 0.0001
Diabetes n (%) 6(15) 10(23) 9(21) 15(37) 0.07 0.1
FHx heart disease n(%) 7(17) 11(25) 21(50) 14(34) 0.6 0.004
Smokers (Current/Ex/Never) 12/20/9 8/12/23 4/29/9 3/16/21 0.0005 0.2
Maximal hyperaemia (au)* 145(130-162) 141(131-153) 117(105-131) 111(101-122) 0.4 < 0.0001
Reactive hyperaemia (au)* 57(49-67) 49(43-56) 44(38-50) 39(34-45) 0.06 0.0007
* Log transformed data
p = significance between disease and control group and between each ethnic group two way analysis of variance (ANOVA), with test for interaction
No known CAD (Coronary artery disease) recruited from general practice register with no documented history of, or medications suggested of coronary artery
disease.
Established CAD recruited with established symptomatic atherosclerotic coronary artery with at least one > 50% stenosis and evidence of other atherosclerotic
disease on angiography
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with lower HbA1c and lower fasting insulin level(data
not shown). Reactive hyperaemia was negatively asso-
ciated with waist hip ratio and HbA1c. There was a
weak association between maximum hyperaemia and
diastolic blood pressure, but not with any other mea-
sure of blood pressure. There was no association
between age and either maximum hyperaemia or reac-
tive hyperaemia in the population as a whole, either by
ethnicity or by recruitment group, as has been pre-
viously demonstrated in other populations[10,21].
Neither an age-stratified analysis (data not shown) nor
adjustment for differences in age and risk factors made
any material difference to the difference between the
CAD +ve and CAD -ve groups. The modest difference
in reactive hyperaemia between the ethnic groups was
accounted for by dysglycaemia (table 2), however mul-
tivariate adjustment for age and smoking history and
measures of blood pressure, dyslipidaemia and dysgly-
caemia did little to attenuate the impairment in both
maximal and reactive hyperaemia seen in the CAD +ve
group compared to the CAD -ve controls of each eth-
nic group.
Discussion
We have demonstrated that patients presenting to car-
diac services with symptomatic atherosclerotic coronary
artery disease have systemic microvascular dysfunction
detectable in the skin, independent of conventional car-
diac risk factors. Contrary to our expectations, however,
we did not detect an attenuation of microvascular func-
tion in those CAD +ve patients of Indian Asian origin
compared to Europeans, despite increased measures of
insulin resistance.
Evidence from population studies suggest Indian Asians
present with diabetes at a younger age and have more
macro and microvascular complications[8,22]. In keeping
with this, subjects in our Indian Asian cohort were
younger and had a trend towards a greater prevalence of
diabetes. We demonstrated a trend towards poorer reac-
tive hyperaemia in the Indian Asians compared to their
European counterparts, however this is accounted for by
differences in glycaemic control. Clearly this study cannot
determine whether dysglycaemia represents the mechan-
ism of the association or is simply a confounding variable
of other pathways such as the presence of molecular or
autonomic changes, that might also be ethnicity related.
Our hypothesis that Indian Asians would have attenuated
microvascular function compared to their European coun-
terparts was based on the premise that microvascular dys-
function would precede the development of symptomatic
atherosclerosis and continue to deteriorate as athero-
sclerotic burden increases.
Urinary albumin excretion rate independently predicts
cardiovascular mortality in diabetes[23], hypertension
[24], and the general (largely non-diabetic) population
right into the normal range [25-27]. Of course, this does
not mean the process of increasing urinary albumin
excretion, nor other measures of microvascular function
as reported here, are truly independent of atherosclero-
sis. If, for example, the process that leads to sympto-
matic atherosclerosis is related to the process resulting
in microvascular dysfunction either due to shared risk
factors, shared susceptibility to said risk factors or as
part of the same aetiopathogenic process, AER and car-
diovascular risk will mirror each other but be indepen-
dent. This is supported by the lack of association
between conventional risk factors of atherosclerosis and
microvascular measures, despite the clear differences in
populations with and without proven cardiovascular dis-
ease. The impact of the multifactorial complexity of this
process cannot be explored in this cross-sectional study,
but requires longitudinal follow-up of these patients.
The failure to demonstrate an ethnic difference, there-
fore, may be a result of a selection bias, by recruiting
those with a demonstrable susceptibility (CAD +ve) or
resistance (CAD -ve) to the pathogenic steps that lead
to atherosclerosis, or a genuine lack of ethnic difference
in microvascular function. Within the population we are
able to detect a difference of approximately 0.23 SD of
any given variable with 80% power at 5% significance.
Although smaller differences may be present, the clinical
Table 2 Microvascular parameters stratified by coronary artery disease group in each ethnic group presented as
geometric mean (95% CI) after adjustment for age, mean arterial blood pressure, total cholesterol, HbA1c and
smoking history
No known CAD Established CAD P by
Variable Europeans Indian Asians Europeans Indian Asians Ethnicity CAD group
Maximum hyperaemia (au) 139(125-155) 146(131-163) 114(102-128) 114(101-127) 0.3 0.002
Reactive hyperaemia (au) 58(50-68) 48(41-56) 41(33-49) 43(37-51) 0.5 0.006
No known CAD (Coronary artery disease) recruited from general practice register with no documented history of, or medications suggested of coronary artery
disease.
Established CAD recruited with established symptomatic atherosclerotic coronary artery with at least one > 50% stenosis and evidence of other atherosclerotic
disease on angiography
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significance.
Study limitations
T h i si sac r o s ss e c t i o n a ls t u d yh e n c ew ec a n n o tr e l i a b l y
draw conclusions on cause or effect. By consecutively
recruiting CAD+ve patients then age and ethnicity
matching control subjects, there is an age discrepancy
between the ethnic groups, such that the Indian Asians
are younger. Although there is only a weak associated
between age and microvascular function within our
populations, it is possible that this difference in age may
contribute to the lack of difference. However an age-
stratified analysis, demonstrating similar inter-ethnic
regression coefficients for microvascular measures in
each 5-year age stratum, makes this an unlikely
explanation.
Conclusion
Contrary to expectations, we did not detect an ethnic
difference in microvascular function between Indian
Asians and Europeans either from the general popula-
tion or with confirmed coronary artery disease. There is,
however, attenuated skin microvascular function in
patients attending cardiology services with proven ather-
osclerotic disease compared to a general population
sample independent of conventional cardiovascular risk
factors such as blood pressure smoking, dyslipidaemia
and dysglycaemia. Further exploration of the aetiopatho-
genic association between coronary artery disease and
microvascular dysfunction may guide research into
novel therapeutic interventions.
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